• All fields are required unless indicated optional

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit

Our apologies...

An error has occurred while submitting. Please try again later...

Thank you!

Your form was submitted successfully

Surgeons using Prevena Therapy for vascular surgery

Prevena Central for vascular surgery

Convenient. Curated. Connected. Training for the use of 3M™ Prevena™ Therapy in vascular surgery.

REQUEST A DEMONSTRATION
  • In a prospective, single-center, randomized controlled trial with patients undergoing vascular groin surgery, Prevena Therapy aided in:

Prevena for vascular surgery statistics
  • Calculations are derived based on relative patient group incidence rate reported in this study.

    *Statistically significant (p<0.05).

    1. Kwon J, et al. A Randomized Clinical Trial Evaluating Negative Pressure Therapy to Decrease Vascular Groin Incision Complications. Journal of Vascular Surgery. 2018;68(6):1744-1752.

Proactive Risk Management (PRM) with Prevena Therapy

Implement PRM to help protect your high-risk patients. See the evidence behind the use of Prevena Therapy in vascular surgery.

Prevena Central horizontal rule

Surgeon testimonials

  • Dr. Dillavou 3M™ Prevena™ Therapy Journey Video

    Dr. Dillavou 3M™ Prevena™ Therapy Journey Video

Prevena Central horizontal rule

Application videos

Prevena Central horizontal rule
Purple gradient
Connect with a 3M representative

Learn more about the use of Prevena Therapy in vascular surgery or request a product demonstration.

CONTACT A REP

3M™ Prevena™ 125 and 3M™ Prevena™ Plus 125 Therapy Units manage the environment of closed surgical incisions and remove fluid away from the surgical incision via the application of -125mmHg continuous negative pressure. When used with legally marketed compatible dressings, Prevena 125 and Prevena Plus 125 Therapy Units are intended to aid in reducing the incidence of seroma and, in patients at risk for post-operative infections, aid in reducing the incidence of superficial surgical site infection in Class I and II wounds.

The effectiveness of Prevena Therapy in reducing the incidence of SSIs and seroma in all surgical procedures and populations has not been demonstrated. See full indications for use and limitations at myKCI.com.

NOTE: Applicable therapy units include Prevena™ 125 and Prevena™ Plus 125 Therapy Unit 7 Day.

The indication statement does not apply to the Prevena Plus 125 Therapy Unit (14-day) that comes with the 3M™ Prevena Restor™ System Kits (see Prevena Restor indications for use).

The 3M™ Prevena Restor™ Incision Management System is intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudate via the application of negative pressure wound therapy.

NOTE: Specific indications, limitations, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. Rx only.